Pituitary Adenomas

Pituitary adenomas (PA) are a common type of endocrine neoplasia that is usually benign. PA have a high rate of clinical morbidity due to hormonal hypersecretion, neurological symptoms from cerebral mass effects or invasion of adjacent structures, and secondary hypopituitarism. Pharmacological treatment, primarily dopamine agonists (DA) and somatostatin analogues (SSA), surgery, and radiotherapy are being used to treat them [2]. Despite substantial progress in the treatment of PA, a significant portion of individuals remain uncontrollably ill. Long-term uncontrolled pituitary hormone hypersecretion, which can lead to serious systemic illnesses as well as tumour recurrence or aggressiveness, is still a difficult clinical problem.



 


    Related Conference of Pituitary Adenomas

    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    May 08-09, 2025

    5th European Endocrinology and Diabetes Congress

    Madrid, Spain
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France

    Pituitary Adenomas Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in